Bernard Gilly is an accomplished executive with a strong background in biotechnology and pharmaceuticals. Currently serving as CEO at BrainEver since September 2015, Bernard also holds the position of Chairman at iBionext. Bernard has a notable tenure as CEO of GenSight Biologics from January 2013 to January 2024 and previously led Fovea Pharmaceuticals / Sanofi as CEO from 2005 to 2012. Prior to these roles, Bernard was a Partner at Sofinnova Partners from 2000 to 2005 and held the position of CEO at Transgene from 1992 to 2000. Bernard began a distinguished career at PMC / Sanofi Pasteur as VP of R&D from 1987 to 1994.
This person is not in the org chart
This person is not in any teams
This person is not in any offices